# Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect?

> **NCT05102396** · PHASE2 · RECRUITING · sponsor: **Samantha Rodrigues Camargo Neves de Moura** · enrollment: 17 (estimated)

## Conditions studied

- Hyperhidrosis
- Oxybutynin
- Sweat Gland Diseases
- Skin Diseases
- Autonomic Agents
- Cholinergic Antagonists
- Parasympatholytics

## Interventions

- **DRUG:** Topical oxybutynin spray
- **DRUG:** Topical placebo spray
- **DRUG:** Oral oxybutynin

## Key facts

- **NCT ID:** NCT05102396
- **Lead sponsor:** Samantha Rodrigues Camargo Neves de Moura
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-26
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-08-30
- **Target enrollment:** 17 (ESTIMATED)
- **Last updated:** 2024-05-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05102396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05102396, "Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect?". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05102396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*